Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy.

导出 OA

翻译打印收藏纠错

第一作者： Estelle,Tran Van Hoi

第一单位： Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.

作者： Estelle,Tran Van Hoi ^[1] ; Saskia J,Santegoets ^[2] ; Simon P,Mooijaart ^[3] ; Diana,Van Heemst ^[1] ; Asli,Özkan ^[4] ; Elizabeth M E,Verdegaal ^[4] ; Marije,Slingerland ^[4] ; Ellen,Kapiteijn ^[4] ; Sjoerd H,van der Burg ^[2] ; Johanneke E A,Portielje ^[4] ; Marij J P,Welters ^[2] ; Nienke A,de Glas ^[5]

作者单位： Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands. ^[1] Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.;Oncode Institute, Utrecht, The Netherlands. ^[2] Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.;LUMC Center for Medicine for Older People, Leiden University Medical Center, Leiden, The Netherlands. ^[3] Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. ^[4] Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands. N.A.de_Glas@lumc.nl.;Department of Oncology, Helse Førde, Førde, Norway. N.A.de_Glas@lumc.nl. ^[5]

关键词 Frailty Immune biomarkers Immunotherapy by checkpoint inhibition Melanoma cancer

DOI 10.1186/s12979-024-00463-y

PMID 39593063

发布时间 2024-11-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交